Table: Mitsubishi Chemical HD -6-MTH group results (IFRS)
Nov 2 (Reuters)-
Mitsubishi Chemical Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 1.89 trln 1.50 trln 3.89 trln
(+25.3 pct) (-17.7 pct) (+19.3 pct)
Operating 153.14 loss 28.13 344.00
(+623.9 pct)
Pretax 147.17 loss 36.80 328.00
(+896.7 pct)
Net 85.17 loss 49.69 192.00
EPS Basic 59.94 yen loss 34.99 yen 135.12 yen
EPS Diluted 55.13 yen loss 34.99 yen
Ann Div 24.00 yen 30.00 yen
-Q2 Div 15.00 yen 12.00 yen
-Q4 Div 12.00 yen 15.00 yen
NOTE - Mitsubishi Chemical Holdings Corp.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)